BIO-GIDE MEMBRANE (30-8013)

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2012-03-13 for BIO-GIDE MEMBRANE (30-8013) manufactured by Geistlich Pharma Ag.

Event Text Entries

[2634705] On (b)(6) 2012, a spontaneous report was received from a physician involving bio-gide membrane. Additional information was received on (b)(6) 2012. This involved a (b)(6) female with a medical history of right knee pain secondary to right knee cartilage "wearing away"; also reported as an osteochondral defect. Concomitant medications and known drug allergies were not reported. In (b)(6) 2011, the patient underwent cartilage cell implantation with bio-gide used as a scaffold (meddra coded off label use). The physician reported that immediately post operatively, the patient experienced a swollen right knee with effusion (meddra coded joint swelling and joint effusion). As of (b)(6), the physician reported the patient had not been treated with antibiotics nor additional surgical treatments. In (b)(6), 2012, an mri revealed the patient had developed right knee inflammation (meddra coded arthritis) and right patellar degradation (meddra coded bone disorder). (b)(6) 2012 lab results included an elevated ige of 183 (high normal reported as 114) (meddra coded blood immunoglobulin e increased). The patient was scheduled for consultations with an allergist and a rheumatologist the week of (b)(6) 2012. On (b)(6) the physician considered the right knee inflammation most likely due to bio-gide. On (b)(6), the physician reported the patient continued to experience recurrent effusions and the bone graft fell apart (details not provided). Bovine and porcine were not positive on allergy testing and the physician did not feel the events were related to bio-gide. On (b)(6) 2012, additional information was received from the physician, a surgeon, who confirmed that the bio-gide membrane was used to contain the patient's own chondrocyte cells used for implantation as treatment for an osteochondral defect in the medial femoral condyle. The patient did complete the post operative physical therapy that was prescribed. The patient continued to have swelling in the knee. A rheumatoid work up was negative for allergies. Two aspirations from the knee were negative for infection. On (b)(6) 2012, the patient underwent "reconstruction surgery" using autologous tissue referred to as a "sandwich procedure". The surgeon described this as a procedure in which the patient's periosteum was used as a patch. During the second procedure he found sclerotic bone. Biopsies were obtained and sent out and pathology results were pending. The physician felt that a vitamin d deficiency was contributing to the patient's reactions and stated again that he did not feel the reactions were caused by the bio-gide membrane. Patient outcome was not reported.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2410375-2012-00001
MDR Report Key2573353
Report Source05
Date Received2012-03-13
Date of Report2012-03-08
Date of Event2011-03-01
Date Mfgr Received2012-02-10
Date Added to Maude2012-05-15
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer StreetP O BOX 9001
Manufacturer CitySHIRLEY NY 11967
Manufacturer CountryUS
Manufacturer Postal11967
Manufacturer Phone6319244000
Single Use0
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameBIO-GIDE MEMBRANE (30-8013)
Generic NameNONE
Product CodeNPK
Date Received2012-03-13
Lot NumberUNKNOWN
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerGEISTLICH PHARMA AG
Manufacturer AddressBAHNHOFSTRASSE 40 PO BOX 157 WOLHUSEN 6110CH 6110 CH


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2012-03-13

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.